Schwann Cell Precursors; Multipotent Glial Cells in Embryonic Nerves by Jessen, KR & Mirsky, R
REVIEW
published: 26 March 2019
doi: 10.3389/fnmol.2019.00069
Edited by:
Virginie Neirinckx,
Luxembourg Institute of Health (LIH),
Luxembourg
Reviewed by:
Joao Relvas,
i3S, Instituto de Investigação e
Inovação em Saúde, Portugal
Gang Chen,
Nantong University, China
*Correspondence:
Kristjan R. Jessen
k.jessen@ucl.ac.uk
Received: 10 December 2018
Accepted: 04 March 2019
Published: 26 March 2019
Citation:
Jessen KR and Mirsky R
(2019) Schwann Cell Precursors;
Multipotent Glial Cells in
Embryonic Nerves.
Front. Mol. Neurosci. 12:69.
doi: 10.3389/fnmol.2019.00069
Schwann Cell Precursors;
Multipotent Glial Cells in Embryonic
Nerves
Kristjan R. Jessen* and Rhona Mirsky
Department of Cell and Developmental Biology, University College London, London, United Kingdom
The cells of the neural crest, often referred to as neural crest stem cells, give rise to
a number of sub-lineages, one of which is Schwann cells, the glial cells of peripheral
nerves. Crest cells transform to adult Schwann cells through the generation of two
well defined intermediate stages, the Schwann cell precursors (SCP) in early embryonic
nerves, and immature Schwann cells (iSch) in late embryonic and perinatal nerves. SCP
are formed when neural crest cells enter nascent nerves and form intimate relationships
with axons, a diagnostic feature of glial cells. This involves large-scale changes in gene
expression, including the activation of established glial cell markers. Like early glia in the
CNS, radial glia, SCP retain developmental multipotency and contribute to other crest-
derived lineages during embryonic development. SCP, as well as closely related cells
termed boundary cap cells, and later stages of the Schwann cell lineage have all been
implicated as the tumor initiating cell in NF1 associated neurofibromas. iSch are formed
from SCP in a process that involves the appearance of additional differentiation markers,
autocrine survival circuits, cellular elongation, a formation of endoneurial connective
tissue and basal lamina. Finally, in peri- and post-natal nerves, iSch are reversibly induced
by axon-associated signals to form the myelin and non-myelin Schwann cells of adult
nerves. This review article discusses early Schwann cell development in detail and
describes a large number of molecular signaling systems that control glial development
in embryonic nerves.
Keywords: Schwann cell precursor, neural crest, nerve development, PNS, Schwann cell lineage, PNS glia,
multipotent glia
INTRODUCTION
The cells of the neural crest often referred to as neural crest stem cells, give rise to a number of
sub-lineages, one of which is the glial cells of the peripheral nervous system (PNS). This group of
cells includes the myelin and Remak (non-myelin) Schwann cells in peripheral nerves, terminal
Schwann cells at the neuromuscular junction, satellite glial cells in ganglia and enteric glial cells in
the gut. This review article will focus on the appearance of the Schwann cell sublineage, the major
PNS glial population and the one that has been most intensively studied.
In rodents, neural crest cells transform to Schwann cells of adult nerves through the
generation of two well defined intermediate stages. These are the Schwann cell precursors
(SCP) in early embryonic nerves, and immature Schwann cells (iSch) in late embryonic
and perinatal nerves (Figure 1). The lineage therefore includes three main developmental
transitions: (1) the formation of SCP from crest cells; (2) the generation of iSch from SCP;
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FIGURE 1 | Main transitions in the Schwann cell lineage. A scheme illustrating key cell types involved in Schwann cell development, and in nerve repair. Also shown
are the alternative cells that can develop from Schwann cell precursors (SCP) in addition to immature Schwann cells (iSch). Black uninterrupted arrows: normal
developmental transitions. Red arrows: the Schwann cell injury response. Stippled arrows: post-repair formation of myelin and Remak cells (with permission from
Jessen et al., 2015b).
and (3) the mostly postnatal divergence of iSch to adopt the
strikingly different phenotypes of myelin and Remak (non-
myelin) Schwann cells (Jessen and Mirsky, 2005a; Jessen
et al., 2015b; Monk et al., 2015). A fourth major phenotypic
transformation potentially takes place in the adult. This is
triggered by nerve injury which transforms myelin and Remak
cells to repair Schwann cells, cells that are specialized to
support nerve regeneration (Jessen and Arthur-Farraj, 2019;
Jessen and Mirsky, 2016).
This review article will focus on the embryonic phase of
Schwann cell development. We will discuss the phenotype and
biology of SCP, the generation and the distinctive properties
of iSch, and the signals that control survival, proliferation and
lineage progression in this system.
OUTLINE OF THE NEURAL CREST
SCHWANN CELL LINEAGE
Schwann Cell Precursors (SCP)
SCP are found in mouse embryonic nerves at embryo day
(E) 12–13 (rat E14–15). These cells have the characteristic
phenotype of glial cells as we will discuss in the following section.
Interestingly, SCP appears to retain the stem-cell-like feature of
developmental multipotency, a cell biological feature that they
share with early glial cells in the CNS, the radial glia (Pinto
and Götz, 2007; Kriegstein and Alvarez-Buylla, 2009). SCP are
closely integrated with axons in newly formed nerves and rely
acutely on axonal signals for survival. Axons and associated SCP
form the compact structures of embryonic nerves, from which
connective tissue is excluded. Present evidence indicates that SCP
are restricted to embryonic nerves, and these cells have not been
shown to take part in the maintenance of adult nerves or in the
response of peripheral nerves to injury.
Immature Schwann Cells (iSch)
SCP form iSch that are present in mouse nerves from E15–16
(E17–18 in rat) extending to the perinatal period. iSch associate
with connective tissue and basal lamina inside nerves, which
at this stage also contain blood vessels, and do not depend on
axons for survival. Starting around birth, these cells take part in a
process termed radial sorting (Feltri et al., 2016). This generates
Schwann cells in a 1:1 ratio with the larger diameter axons.
In rodents, these cells are referred to as pro-myelin cells and
they mostly go on to form myelin sheaths. In humans, however,
many axons in a 1:1 ratio remain unmyelinated. The smaller
axons do not take part in radial sorting, but gradually associate
with iSch by taking up a position in shallow troughs along their
surface, thus forming Remak bundles (Jessen and Mirsky, 2005a;
Monk et al., 2015).
Axonal Signals
Schwann cell development is to a striking degree dependent
on and driven by, axon-associated signals. They ensure the
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survival of SCP and promote their differentiation, determine
whether iSch differentiate as myelin or Remak cells and govern
the highly specialized architecture and molecular expression
of myelin Schwann cells. Signals from axons also drive the
proliferation of developing Schwann cells until they fall out of
division at the pro-myelin stage (Webster and Favilla, 1984). In
undisturbed adult nerves, myelin and Remak cells are mitotically
quiescent but transiently re-enter the cell cycle after nerve
injury and in some pathological conditions (Chen et al., 2007;
Stierli et al., 2018).
Boundary Cap Cells
The present article deals with Schwann cell development
as elucidated in studies on spinal nerves, such as the
developing sciatic nerve. Other studies have focussed on
Schwann cells, and other cellular derivatives that emerge
from a distinct sub-population of crest cells, called boundary
cap sells (Maro et al., 2004; Coulpier et al., 2009; Radomska
and Topilko, 2017). Boundary cap derived Schwann cells
are particularly important in ensheathing the axons of
the spinal nerve roots. They have a distinct molecular
signature, including early expression of the pan Schwann
cell marker S100 and the transcription factor Krox20
(Egr2), which is a key regulator of myelination in peri- and
post-natal nerves.
SCHWANN CELL PRECURSORS SHOW AN
OBVIOUS GLIAL-LIKE PHENOTYPE
In adult nerves, themyelin protein zero (mpz) gene which encodes
the major myelin protein zero (P0), is strongly expressed in
myelin Schwann cells and restricted to these cells. But after
nerve injury, the gene is rapidly activated to achieve a low,
basal level of expression in Remak cells as they loose axonal
contact. Similarly during development, low, basal levels of mpz
gene expression are seen long before myelination. It is readily
detected in iSch and SCP and is seen in a subpopulation of neural
crest cells even before axonal outgrowth from the ventral part
of the developing spinal cord (Figure 2; Bhattacharyya et al.,
1991; Lee et al., 1997, 2001). As the first axons extend into the
mesenchyme, mpz expressing cells accumulate nearby, and soon
afterward they integrate with the axons to form a compact early
spinal nerve.
Electron microscopy of these nerves shows that these cells,
SCP, are intimately associated with large bundles of axons,
which they envelop communally with flattened membranous
processes (Figures 3, 4A). In larger nerve branches, the cells
embed themselves deep among the axons, and they are also
tightly associated with axons at the nerve surface, both in
small and large nerve branches (Jessen and Mirsky, 2005a;
Wanner et al., 2006b).
When neural crest cells that migrate in the mesenchyme
convert to SCP that reside within nerves, they change the
expression of several hundred genes (Buchstaller et al., 2004).
Two to three-fold higher number of genes are up-regulated
than down-regulated, and up-regulated genes include a broad
spectrum of functional classes, such as transcription factors,
cell cycle regulators, cytoskeleton-associated molecules and
molecules involved in cell growth and differentiation. Large
number of these genes, such as the genes encoding for MBP,
PLP22, desert hedgehog (Dhh) and BFABP, are Schwann
cell-associated in the sense that their expression persists
or is further up-regulated during subsequent Schwann cell
development (Figure 5; Jaegle et al., 2003; Buchstaller et al.,
2004; Takahashi and Osumi, 2005; D’Antonio et al., 2006b;
Li et al., 2007).
The SCP described here are glial cells for the following
reasons. First, the tight and intimate association with neurons
and their processes, and envelopment of axons is a defining
feature of glial cells in the normal PNS and CNS, and this
holds true both for development and the adult state. Second,
the transition from crest cells to SCP involves large-scale
changes in gene expression, and among the genes that are
activated in SCP are many glial-associated genes that are
also expressed by Schwann cells (Figure 5). Third, SCP, but
not crest cells, are strikingly dependent on axonal signals for
survival and differentiation. This is a characteristic feature of
Schwann cells, where axonal signals are essential for proliferation
and differentiation. Neuregulin 1 (NRG1) type III is a major
axonal signal controlling both SCP survival and Schwann cell
differentiation. Accordingly, in NRG1 mutants, SCP and iSch
are depleted from peripheral nerves although neural crest cells
survive and generate crest derivatives such as dorsal root ganglia
(DRG) neurons and satellite cells (Birchmeier and Nave, 2008;
Birchmeier, 2009).
In addition to the above, other difference between crest
cells and SCP is their contrasting response to potential survival
factors, including IGF1, endothelin, PDGF and NT3 and
cell substrates such as laminin and fibronectin (Woodhoo
et al., 2004). Further, in comparison to neural crest cells,
SCP are not sensitive to the neurogenic effect BMP2 and
are biased towards the generation of iSch (Kubu et al., 2002;
Woodhoo and Sommer, 2008).
EARLY GLIAL CELLS IN THE PNS AND
CNS ARE MULTIPOTENT
The SCP in newly formed embryonic nerves represent the
earliest well defined glial-like cell in the development of the
PNS. In CNS development, the best-studied early glial cell is
the radial glial cell, a cell that conforms to the phenotype
of glial cells on the basis of ultrastructural, molecular and
cell biological criteria, much like SCP (Pinto and Götz, 2007).
Radial glia have now been shown to be multipotent and to
directly or indirectly generate neurons and oligodendrocytes,
although these cells were initially thought to generate only
astrocytes (Malatesta and Götz, 2013). It is therefore not
surprising that SCP share this feature of multipotency, and
can give rise to other cell types during development in
addition to iSch.
Cell culture studies first showed that SCP were not restricted
to forming Schwann cells only (Ciment et al., 1986; Morrison
et al., 1999; Dupin et al., 2000). The first demonstration
of this in vivo was a study of fibroblast generation using
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FIGURE 2 | Myelin protein zero (mpz) gene expression at the onset of Schwann cell development. (A) In situ hybridization showing mpz expression in iSch of
embryonic (E16) rat nerves (nerve in developing limb arrowed). (B) In situ hybridization showing an initial appearance of mpz expression in scattered neural crest cells
at the level with the ventral developing spinal cord (e.g., arrow). Strong mpz labeling is also seen in the notochord. Transverse section from an E9/10 rat embryo. (C)
When axons emerge from the ventral spinal cord (shown by TuJ1 immunolabeling in the lower panel), mpz expressing cells cluster nearby (upper panel). Transverse
section from an E10/11 rat embryo. (D) In E12/13 rat embryo, mpz expression is seen in nascent spinal nerves (asterisk), and in the ventral root and ventral and
lateral aspects of the dorsal root ganglion (G) (with permission, modified from Lee et al., 1997).
Cre-lox-based based lineage tracing in mice (Joseph et al.,
2004). Unlike the CNS, peripheral nerves contain a substantial
amount of connective tissue and therefore fibroblasts (5%–10%
of the number of Schwann cells at birth; Jessen and Mirsky,
2005a). These cells could be traced to cells in the nerve
that express Dhh, a gene that is expressed in SCP and
iSch but not in the neural crest, and which controls the
correct formation of the perineurial nerve sheath (Parmantier
et al., 1999; Jaegle et al., 2003; Joseph et al., 2004; Sharghi-
Namini et al., 2006). The finding that SCP convert to
both iSch and fibroblasts is in good agreement with the
observation that in developing nerves the appearance of iSch and
fibroblasts is temporarily linked with the disappearance of SCP
(Wanner et al., 2006a).
There is also in vivo evidence that some neurons in
the enteric nervous system of the gut wall arise from SCP
(Uesaka et al., 2015; Espinosa-Medina et al., 2017), and the
same applies to neurons in parasympathetic ganglia (Dyachuk
et al., 2014; Espinosa-Medina et al., 2017). In the case of
parasympathetic neurons, there is evidence that SCP that express
Phox2b preferentially generate neurons, while this factor is
downregulated in SCP that generate iSch. SCP also give rise
to a significant number of adrenal chromaffin cells, activating
Phox2b and Ascl1 expression as they migrate from embryonic
nerves (Furlan et al., 2017). Similarly, some SCP in distal nerves
escape NRG1 signaling from axons as they generate melanoblasts
and emigrate to take up appropriate location in the nearby
developing skin and develop to melanocytes, a process that
requires downregulation of the transcription factor Foxd3 and
cross-regulatory interactions between the transcription factors
Sox2 and Mitf (Adameyko et al., 2009, 2012; Nitzan et al.,
2013). Lastly, mesenchymal stem cells in the teeth that produce
odontoblasts and tooth pulp cells can originate in SCP (Kaukua
et al., 2014; Kalcheim and Kumar, 2017).
Thus, both radial glia and SCP show the stem cell-like feature
of multipotency, although it cannot be excluded that in vivo some
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FIGURE 3 | The tight association between SCP and axons in developing
peripheral nerves. This electron micrograph shows a transverse section
through the sciatic nerve of an E14 rat embryo. Note the intimate association
between large groups of axons and SCP, and the absence of significant
extracellular spaces and connective tissue. Parts of three SCP are visible.
Part of the nucleus (N) and the cell body of one of them is included in the field.
Arrows point to the junctions between this cell and processes from two other
SCP. Scale bar: 1.7 µm (with permission from Jessen and Mirsky, 2005b).
SCP are already lineage-restricted (Kalcheim and Kumar, 2017).
This interesting property of developing CNS and PNS glial cells
relates differently to lineage progression in the two systems.
In the case of SCP, broad developmental potential represents
the retention of a notable feature of their cell of origin, neural
crest cells, while in radial glia, multipotency appears during
development as a component of the radial glial phenotype.
The capacity of cells with a glial phenotype to generate more
than one cell type can be retained even in the adult. This is seen
in the case of subventricular zone astrocytes, which give rise to
neurons and oligodendrocytes in the mature brain (Kriegstein
and Alvarez-Buylla, 2009).
THE PLASTICITY OF THE SCHWANN CELL
PHENOTYPE
Another example of the ability of glial cells to convert to
different phenotypes is seen in adult nerves, where Schwann
cells retain the capacity to alternate between radically different
Schwann cell phenotypes in response to cell-extrinsic signals.
Thus, it is well established that Remak and myelin cells, although
strikingly different in structure, molecular expression and
function, are potentially interchangeable, the two phenotypes
being exclusively determined by signals from the axons they
associate with. A further instance is the capacity of myelin and
Remak cells to give rise to a third adult Schwann cell phenotype,
the repair Schwann cell, in response to the different signaling
environment generated by nerve injury (Arthur-Farraj et al.,
2012, 2017; Jessen et al., 2015a; Jessen and Mirsky, 2016, 2019;
Gomez-Sanchez et al., 2017). The strong regenerative potential
of peripheral nerves (Chen et al., 2007; Brosius Lutz and Barres,
2014; Cattin and Lloyd, 2016; Jessen and Mirsky, 2019) is
to a significant extent due to this adaptive injury response,
which reprograms myelin and Remak cells to a Schwann cell
that is specialized in morphology and molecular expression to
support repair. Repair Schwan cells engineer the clearance of
myelin, upregulate expression of trophic factors and cell surface
molecules that prevent the death of inured neurons and stimulate
axon regrowth. These cells also elongate and branch to form
compact cellular columns, classically termed Bungner bands,
along which axons regenerate back to their targets (Gomez-
Sanchez et al., 2017). When axons have regenerated, signals
FIGURE 4 | Architectural reorganization of developing nerves. (A) Electron micrograph of a transverse section through E14 rat sciatic nerve. SCP are embedded
among the axons and at the surface of the nerve (big arrows). A dividing SCP is also seen (small tilted arrow). Note that connective tissue (yellow) surrounds the
nerve, but is not found inside the nerve. (B) Electron micrograph of a transverse section through E18 rat sciatic nerve. iSch surround the collection of axons, forming
compact groups (“families”; examples indicated by asterisks). Extensive connective tissue (yellow) containing blood vessels (arrow) is now found inside the nerve
surrounding the families, as well as outside the nerve. Bracket indicates the developing perineurium (scale bar: 4 µm).
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FIGURE 5 | Molecular expression at the main stages of the embryonic Schwann cell lineage. Below the lineage drawing, main cell biological differences between
each developmental each stage are indicated. The molecular markers of each stage divide into three groups: (i) markers that are upregulated at the crest/SCP
transition, and maintained by iSCh (blue); (ii) markers that are upregulated at the SCP/iSch transition (pink); and (iii) markers that present on neural crest cells and
SCP but are downregulated at the SCP/iSch transition (green). For references, see Jessen and Mirsky (2005a) where more detailed comments on gene expression
patterns are provided.
from small and large axons convert repair cells back to the
phenotype of Remak and myelin cells, respectively, thereby
restoring normal nerve function. Lastly, Schwann cell plasticity
is also demonstrated by the pigmentation of injured nerves, since
Schwann cells are the most likely cell of origin of the melanocytes
that appear around nerve fascicles after damage, although
the lineage of these cells has not been directly determined
(Rizvi et al., 2002).
THE GENERATION OF GLIAL CELLS BY
THE NEURAL CREST: THE APPEARANCE
OF SCHWANN CELL PRECURSORS
Much remains to be learned about the molecular signaling that
directs crest cells to enter peripheral nerves, transform to cells
with glial phenotype, and form and intimate association with
axons (Lobsiger et al., 2002; Woodhoo and Sommer, 2008;
Jacob, 2017; Kalcheim and Kumar, 2017). Although neither
transcription factors nor cell-extrinsic signals that uniquely
specify these events have been identified, recent work has
revealed that histone deacetylase 1/2 (HDAC1/2) and the
transcription factor Sox10 have an important role in this process.
This will be outlined in the subsequent sections, together with
earlier studies on NRG1 and Notch.
Histone Deacetylase (HDAC) 1/2
Enzymes and complexes controlling chromatin remodeling
take part in governing the development of Schwann cells in
embryonic nerves and postnatal myelination. After an injury,
they also influence the generation of the repair Schwann cell
phenotype and the re-myelination (Jacob, 2017; Ma and Svaren,
2018). HDAC1/2 control the formation of SCP from crest cells
by combining with the Sox10 to activate Pax3, a protein that
has long been implicated in early Schwann cell development
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(Grim et al., 1992; Doddrell et al., 2012; Jacob et al., 2014).
Together Sox10 and Pax3 activate the MSCS4 Sox10 enhancer
to promote the crest/SCP transition (Wahlbuhl et al., 2012).
A complex involving Pax3, Sox10 and HDAC1/2 activates the
mpz promoter and thereby initiates a low-level expression of
P0 protein and mRNA, which is a marker of early development
of glial cells from the crest as mentioned in the previous
section ‘‘Schwann Cell Precursors Show an Obvious Glial-Like
Phenotype’’; (Lee et al., 1997). Sox10 also interacts with the fabp7
promoter to initiate expression of BFABP, and other markers of
the crest/SCP transition (Jessen and Mirsky, 2005a; Jacob, 2017).
Sox10
Sox10 has an extensive involvement in Schwann cell
development, from the emergence of the lineage to the regulation
of the transcription factors Oct6 and Krox20 (Egr2) that control
myelination (Schreiner et al., 2007; Svaren and Meijer, 2008;
Finzsch et al., 2010). In line with this, Sox10 potentially functions
to maintain expression of ErbB3 receptors for NRG1, a signal
with a broad role in the Schwann cell lineage (Britsch et al.,
2001). In neural crest cells, there is evidence that Sox10 is also
important for maintenance of developmental multipotency in
combination with other factors such as Notch (Kim et al., 2003;
Wahlbuhl et al., 2012). In mice with genetic inactivation of
Sox10, the crest initially generates neurons in DRG normally.
However, in the absence of Sox10, the emergence of the glial
component fails, since both satellite glial cells in the ganglia,
and SCP in peripheral nerves are missing (Britsch et al., 2001;
Sonnenberg-Riethmacher et al., 2001; Wahlbuhl et al., 2012).
Nevertheless, Sox10 does not uniquely specify PNS glia, because
this protein is found in essentially all neural crest cells and
initially in developing melanocytes.
NRG1
NRG1 is broadly involved in controlling Schwann cell biology
(Birchmeier and Nave, 2008; Birchmeier, 2009; Monk et al.,
2015). But there are a number of reasons why this factor is
unlikely to be required for the generation of glial cells from
the neural crest. First, Schwann cells are generated in spite of
inactivating mutations in the NRG1 receptor ErbB3 in zebrafish
(Lyons et al., 2005). Second, a major category of PNS glia
closely related to Schwann cells, satellite cells in DRG ganglia,
appear to been normally generated in mice in which functional
NRG1 or the NRG1 receptors ErbB2 and ErbB3 are missing.
Third, cells expressing the SCP markermpz mRNA are normally
generated in rat neural crest cultures without the addition of
NRG1 (Lee et al., 1997; Woodhoo et al., 2009). GFAP positive
Schwann cells also emerge readily in neural crest without NRG1
(Shah et al., 1994). Exposure to NRG1 increases the number of
GFAP positive cells in such cultures, an effect likely to reflect
the well-established role of NRG1 as a survival factor, mitogen
and lineage progression factor for SCP, functions that will be
discussed in a later section. All of this argues that NRG1 is
unlikely to be required for the conversion of crest cells to
glial cells.
Indirectly, NRG1 may, however, boost gliogenesis, since in
crest cultures NRG1 is a potent inhibitor of neurogenesis. It can
be speculated that this would increase the time during which
crest cells are exposed to gliogenic signals and therefore promote
gliogenesis (Shah et al., 1994).
Notch
During CNS development, Notch supports the generation of
glial cells (Kubu et al., 2002; Yoon and Gaiano, 2005; Louvi
and Artavanis-Tsakonas, 2006). The number of GFAP positive
Schwann cells that appear in neural crest cultures is increased
by Notch activation, GFAP, however, is not a maker of SCP
generation, but of the later event of iSch appearance from
SCP (Figure 5), and this effect has not been observed in
studies on crest cells from mouse and chick that use the
earlier differentiation marker mpz mRNA, which detects SCP
(Wakamatsu et al., 2000; Woodhoo et al., 2009). Also in ovo,
Notch activation did not stimulate Schwann cell generation
(Morrison et al., 2000). In mice lacking a key mediator
of Notch signaling, the transcription factor RBPJ, Schwann
cells were generated normally, although the emergence of
satellite cells and neurons were impaired (Taylor et al., 2007).
Similarly, the appearance of SCP was unaffected in mice lacking
Hes1 and Hes5, important effectors of canonical Notch signaling
(Woodhoo et al., 2009). These observations argue against Notch
as a significant regulator of the appearance of SCP in spinal
nerves. The increase in GFAP positive Schwann cells in crest
cultures exposed to Notch activation is likely explained by
the strong mitogenic effects of Notch on iSch that appear
in these cultures under the influence of other signals (see
‘‘Notch’’ section).
NRG1 AND NOTCH IN SCHWANN CELL
PRECURSORS
In mice, inactivating mutations in NG1 or the NRG1 receptors
ErbB2 and ErbB3 have a dramatic effect on SCP, which are
radically depleted or absent from embryonic nerves (Birchmeier
and Nave, 2008; Birchmeier, 2009; Taveggia et al., 2010; Monk
et al., 2015). Because NRG1 is unlikely to be needed for SCP
generation (see ‘‘NRG1’’ section), this phenotype points to the
importance of NRG1 for the survival and migration of SCP.
Survival
If SCP are dissociated from nerves of E14 embryos (E12 in the
mouse) and placed in a culture, they undergo apoptotic death
within 12–14 h (Jessen et al., 1994). This contrasts with iSch even
from only 3-day old embryonic nerves, and with Schwann cells
from newborn nerves, since these cells can readily be maintained
in routine culture media (Dong et al., 1995). In vitro, SCP
death can be prevented by co-culturing the cells with neurons
or by culturing them in a neuron-conditioned medium. The
active component in the neuron-conditioned medium has been
identified as NRG, and exogenously applied NRG1 prevents SCP
death (Dong et al., 1995). In vivo, axonal degeneration also
triggers the death of SCP, which is prevented by exposure to
NRG1 (Winseck and Oppenheim, 2006). In mouse embryos,
NRG1 is found on axonal surfaces (Taveggia et al., 2005), and
NRG1 is expressed by DRG andmotor neurons at the stage when
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SCP are present in peripheral nerves. This factor is therefore
expressed at the right place and time to function as a trophic
signal that blocks SCP apoptosis (Marchionni et al., 1993). All of
this suggests that NRG1 on embryonic axons is a key regulator of
SCP survival, and thereby indirectly of Schwann cell generation.
This is likely to be a major reason for the depletion for SCP from
embryonic nerves in NRG and NRG receptor mutants.
Migration
The migration of the trunk neural crest cells is adversely affected
in NRG mouse mutants in which NRG1 signaling is inactivated
(Britsch et al., 1998). Although the cells migrate apparently
normally to the sites of DRG formation, they fail to reach the
more distant sites where sympathetic ganglia are generated. In
zebrafish nerves, NRG1 stimulates the migration of developing
Schwann cells, and in culture, NRG1 enhances migratory activity
of SCP and Schwann cells (Meintanis et al., 2001; Lyons et al.,
2005; Yamauchi et al., 2008; Raphael and Talbot, 2011; Perlin
et al., 2011; Miyamoto et al., 2017). From this, it is likely that
impaired migration contributes to the dramatic reduction on
SCP number in mouse NRG1 mutants.
The Presentation of NRG1 on Developing
Axons
The main NRG1 isoform on axonal surfaces is isoform III, which
therefore mediates most of the effects of NRG1 on SCP and
iSch. Because this protein has two transmembrane domains,
proteolytic cleavage is required to effectively present the active
EGF domain on the axonal surface, allowing it to bind in a
juxtacrine fashion to ErbB2/3 receptors on a nearby glial cell
(Taveggia et al., 2005; Birchmeier, 2009). Proteolysis to activate
NRG1 is carried out by the membrane-associated protease
BACE1 (beta secretase). Another protease which also acts on
NRG isoform lll and affects myelination is TACE (ADAM17; Hu
et al., 2006; Willem et al., 2006; La Marca et al., 2011). It is of
interest that a cytoplasmic domain of axonal NRG1 can engage
in back-signaling and communicate with the neuronal cell body
to stimulate prostaglandin synthesis and myelination (Bao et al.,
2003; Trimarco et al., 2014).
Amplification of NRG1 Signaling by Notch
In addition to NRG1, developing axons also express Notch
ligands, while Notch is found on SCP and iSch. Although axonal
Notch-SCP signaling does not directly support SCP survival, it
amplifies the capacity of NRG1 to do so (Woodhoo et al., 2009).
This is likely explained by the fact that Notch activation increases
the expression of ErbB2 NRG1 receptors on SCP. This effect
is seen when Notch signaling is activated in cultured Schwann
cells and is confirmed in vivo, because reduced ErbB2 levels in
E14 nerves are found in mice with conditional inactivation of
Notch signaling in SCP and iSch (Woodhoo et al., 2009). The
importance of axonal Notch signaling for sustaining ErbB2 levels
and NRG1 signaling from axons to developing Schwann cells
is likely to explain another effect of Notch on SCP. This is the
acceleration of the conversion of SCP to iSch (Woodhoo et al.,
2009). This is seen in vivo, in mice with conditional inactivation
of RBPJ, which transduces canonical Notch signaling, since
these mice show delayed appearance of iSch. Confirming this
role of Notch, iSch appear prematurely in mice where Notch
is overexpressed (Woodhoo et al., 2009). Together these data
indicate that Notch acts as a positive regulator of NRG1 signaling
in embryonic Schwann cell development, thereby indirectly
controlling SCP survival and lineage progression.
A COMPARISON OF IMMATURE
SCHWANN CELLS AND SCHWANN CELL
PRECURSORS
iSch appear in mouse nerves at E15/16 (E 17/18 in rat). The
main phenotypic differences between SCP and iSch include the
following. First, iSch, but not SCP, survive without exposure
to axonal survival signals and suppress apoptosis by autocrine
survival loops (Jessen et al., 1994; Dong et al., 1995; Meier
et al., 1999). Second, iSch and SCP differ substantially in
gene expression (Buchstaller et al., 2004; D’Antonio et al.,
2006b). Among a large number of genes that are up-regulated
at this transition are S100 and GFAP, which are frequently
used markers of iSch, while down-regulated genes include
the transcription factor AP2, α4 integrin, and Ncadherin.
Cadherin19 is up-regulated at the neural crest/SCP transition
but down-regulated at the SCP/iSch transition. It is so far the
only gene known to be expressed selectively in SCP only. Third,
iSch, but not SCP develop a basal lamina (Wanner et al., 2006a).
Fourth, under standard survival conditions in vitro, SCP migrate
at about 10-fold the rate of iSch (Jessen et al., 1994).
Perhaps the most striking difference between SCP and iSch is
in the way their survival is controlled. As mentioned previously,
a population of SCP from E14 (rat; E12 mouse) nerves placed in
culture without neurons dies completely and rapidly, and cannot
be rescued by increasing cell density. This true irrespective of
whether the cells are plated on artificial or extracellular matrix
substrate or exposed to defined or serum-containing medium. In
contrast, iSch fromE17/18 nerves survive under these conditions,
although their survival is markedly density dependent, a classical
indicator of autocrine survival support (Jessen et al., 1994; Dong
et al., 1995, 1999; Gavrilovic et al., 1995; Meier et al., 1999).
The autocrine survival signal consists of a number of factors,
including IGF2, NT3, PDGF-B, leukemia inhibitory factor, and
lysophosphatidic acid (Dowsing et al., 1999; Meier et al., 1999;
Weiner and Chun, 1999).
SIGNALS THAT CONTROL THE
GENERATION OF IMMATURE SCHWANN
CELLS FROM SCHWANN CELL
PRECURSORS
While several signals accelerate or decelerate the generation of
iSch (is in vivo as outlined below), it is notable that exposure
of essentially pure cultures of SCP to NRG1 alone in defined
medium results in the conversion of the SCP to iSch on schedule.
On the basis of a number of criteria, including the appearance
of iSch markers, morphology and appearance of autocrine
survival loops, essentially the whole population of E14 rat SCP
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converts to cells with the phenotype if E18 iSch during 4 days,
matching the time course of Schwann cell generation in vivo
(Dong et al., 1995).
The role of Notch as an appositive regulator of the SCP/iSch
transition was discussed earlier (see ‘‘NRG1 and Notch in
Schwann Cell Precursors’’ section). Another factor involved
in lineage progression is Sox10. This transcription factor is
expressed in neural crest cells and in the Schwann cell lineage
throughout development and in the adult. At the SCP/iSch
transition, dimeric Sox10 is recruited to the Oct6 Schwann cell
enhancer (SCE) which promotes expression of the transcription
factor Oct6 in iSch. Subsequently Oct6, with Sox10 and Brn2,
are recruited to the Krox20 myelin Schwann cell enhancer
(MSE) to increase expression of the pro-myelin transcription
factor Krox20 and permit myelination (Topilko et al., 1994;
Bermingham et al., 1996; Jaegle et al., 1996; Ghislain and
Charnay, 2006; He et al., 2010; Jagalur et al., 2011).
Negative regulation of the appearance of iSch is carried out by
endothelin. Endothelin delays the generation of iSch from SCP in
culture, and in agreement with this inactivation of endothelin B
receptors in vivo causes a premature appearance of iSch (Brennan
et al., 2000). Endothelin B receptor mRNA is suppressed by the
transcription factor Zeb2, which also has a role in controlling
factors that delay myelination (Quintes et al., 2016; Wu et al.,
2016). Another negative regulator is the transcription factor
AP2. In cultured SCP, enforced expression of AP2 retards the
appearance of iSch, and, as might be expected of a negative
regulator of this transition, AP2 is strongly down-regulated as
SCP convert to iSch in vivo (Stewart et al., 2001).
DEVELOPING SCHWANN CELLS
ORGANIZE THE PROTECTIVE TISSUES OF
THE PNS
While the CNS is surrounded by the hard connective tissue of
the skull and vertebrae for protection, the PNS is supported
from within, by the flexible collagen-rich extracellular matrix
of the endoneurial connective tissue that surrounds individual
axon-Schwann cell units. Additionally, nerves are surrounded
by a multi-layered cellular tube, the perineurium, and outside of
that, the collagenous layer of the epineurium. SCP and iSch play
a key role in organizing both these nerve-intrinsic and nerve-
extrinsic protective systems.
The Architectural Transformation of Nerve:
The Generation of Connective Tissue
The SCP/iSch transition coincides with a radical reorganization
of the relationship between nervous tissue and connective
tissue (Wanner et al., 2006a). At the SCP stage, connective
tissue is excluded from nerves and is restricted to the
nerve surround (Figures 3, 4A). These nerves, therefore,
consist exclusively of neurons (axons) and glia. As SCP
progress to generate iSch they also give rise to fibroblasts
that remain within nerves (see ‘‘Early Glial Cells in the
PNS and CNS Are Multipotent’’ section). Fibroblasts secrete
extracellular matrix molecules, especially collagen, which come
to occupy the extracellular spaces that open up within
the nerve at the SCP/iSch transition. At the same time,
this endoneurial connective tissue becomes vascularized and
basal lamina is formed around iSch. Thus, from the iSch
stage (E18 in rat) onwards, peripheral nerves are a mosaic
tissue, consisting of axon-Schwann cell bundles (‘‘families’’
described in newborn nerves; Peters and Muir, 1959; Webster
and Favilla, 1984) intermixed with vascularized connective
tissue (Figure 4B).
The signaling that controls whether SCP generate fibroblasts
or iSch are not known, and the molecular mechanisms
that determine the accompanying changes in cell and tissue
relationships are also unclear, although it has been suggested
that they are related to a strong reduction in the expression of
N-cadherin by SCP and iSch that takes place at this time (Wanner
et al., 2006a).
Signaling Between Glial Cells and
Connective Tissue Directs the Formation
of the Perineurium and Epineurium
The perineurial sheath serves as a nerve-tissue barrier that
protects nerves from unwanted cells and molecules. The cells
of this sheath are covered by a basal lamina and joined
by desmosomes and tight junctions. Although these features,
and the barrier function of the perineurium are typical
of epithelia, the perineurium appears to be derived from
connective tissue (Bunge et al., 1989). The nascent perineurium
can first be discerned in the connective tissue surrounding
developing nerves at the iSch stage in the embryo The
further development of this structure, requires signaling from
developing Schwann cells mediated by Schwann cell Dhh binding
to Patch receptors in the surrounding tissue (Parmantier et al.,
1999). In mice with genetic inactivation of the Dhh gene,
both the perineurium and the surrounding collagen layer of
the epineurium fail to develop properly, and mini-fascicles
made by perineurial-like cells develop within the endoneurium.
This results in failure of the nerve-tissue barrier and a broad-
spectrum nerve pathology, both in the mice, and in humans
with inactivating Dhh mutations (Parmantier et al., 1999;
Umehara et al., 2000).
THE FUNCTION OF SCHWANN CELL
PRECURSORS AND IMMATURE
SCHWANN CELLS
During development, SCP act as a developmental hub, generating
iSch but also diversifying to make contributions to several
cell populations that also originate from the neural crest
along other routes (see ‘‘Early Glial Cells in the PNS and
CNS Are Multipotent’’ section). iSch, however, have narrower
developmental options and serve as a pool from which the
Remak or myelin Schwann cell phenotypes are induced by
cell-extrinsic signaling associated with axons and the basal
lamina. In addition to playing these roles in lineage progression,
SCP and iSch have been implicated in the control of neuronal
survival, nerve fasciculation and the formation of the neuro-
muscular junction.
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Neuronal Survival
Glial cells have long been implicated in the regulation of neuronal
survival, both during development and in the adult. One of
the more compelling observations in this regard comes from
experiments on mice with inactivating mutations in Sox10 or
components of the NRG1 signaling pathway (Riethmacher et al.,
1997; Woldeyesus et al., 1999; Garratt et al., 2000a; Wolpowitz
et al., 2000; Britsch et al., 2001). Because of the importance
of these molecules for Schwann cell development, early PNS
glia cells are missing or found in severely reduced numbers in
these mutants.
Perhaps surprisingly, these mice reveal that early glia are
not important for the initial differentiation of DRG neurons.
Moreover, embryonic nerves containing the axons of motor and
DRG neurons extend towards their target areas broadly following
the normal pattern of nerve outgrowth without early glia. The
unexpected irrelevance of early PNS glia for nerve pathfinding
and outgrowth pattern is confirmed in the Splotch (Pax3)mouse
mutant, where booth SCP and DRG are missing, but nerve
growth pattern remains broadly normal, and by observations on
the initial outgrowth of the lateral line in zebrafish (Grim et al.,
1992; Gilmour et al., 2002; Raphael and Talbot, 2011).
On the other hand, in spite of the fact that without PNS glia
motor and DRG neurons are generated normally in Sox10 or
NRG1 pathway mutants, later in embryonic development, there
is a dramatic loss of both these neuronal populations, especially at
the limb levels (Woldeyesus et al., 1999). This suggests that after
neurogenesis, SCP, iSch and perhaps also satellite cells in ganglia
have an important role in sustaining early DRG and motor
neurons. It is intriguing that because SCP survival depends on
neurons (see ‘‘Survival’’ section) neurons and glia in embryonic
nerves appear to depend on each other for survival.
Nerve Fasciculation and the Formation of
the Neuromuscular Junction
Although the initial pattern of nerve outgrowth towards target
tissues is relatively normal without early PNS glia, within these
tissues nerve branching is aberrant, and without SCP nerves are
poorly fasciculated and disorganized (Woldeyesus et al., 1999;
Wolpowitz et al., 2000).
Similarly, early stages of synapse formation proceed without
accompanying glial cells, including the appearance of some
of the ultrastructural features of the neuromuscular junction
and acetylcholine receptor clustering. Postsynaptic junctional
folds fail to form normally, however, and there are abnormal
terminal sprouting and erroneous location of synaptic sites
(Morris et al., 1999; Woldeyesus et al., 1999; Lin et al., 2000;
Wolpowitz et al., 2000).
In view of the cellular architecture of growing nerve endings,
it is not surprising that nerve terminals fail to behave normally
within target tissues in the absence of accompanying glial cells
(Wanner et al., 2006a). SCP are abundant at the nerve front,
where ultrastructural analysis shows that they generate complex
scaffolds around axonal growth cones. Notwithstanding the
apparently irregular and disorganized aspect of these structures,
a quantitative ultrastructural analysis reveals that the amount of
membrane contact is remarkably constant from one nerve front
to another (Wanner et al., 2006b). This cellular arrangement is
clearly essential for axons to establish normal connections with
their targets.
SIGNALS THAT MATCH THE NUMBERS
OF SCHWANN CELLS TO THE NUMBER
OF AXONS
There is evidence that Schwann cell numbers are controlled
both by signals that induce Schwann cell death and by mitogens
associated with axons, the basal lamina that starts to form at the
iSch stage, and perhaps from other sources within the nerve.
Signals Regulating Survival and Death
Two main factors have been implicated in actively killing
Schwann cells, transforming growth factorβ (TGFβ), acting
through TGFβ type II receptors, and nerve growth factor (NGF)
acting through p75NTR.
TGFβ type II receptors mediate normal developmental death
of Schwann cells in perinatal nerves, presumably functioning
together with the mitogens discussed earlier to achieve correct
cell numbers (D’Antonio et al., 2006a). Although most Schwann
cell survives without axons (see ‘‘Survival’’ section) nerve injury,
especially in neonates, it results in a transient phase of increased
apoptosis (Grinspan et al., 1996; D’Antonio et al., 2006a). This
injury-induced death is also in part mediated by TGFβ acting on
TGFβ type II receptors (D’Antonio et al., 2006a).
NGF acting through p75NTR does not appear to take part
in the control of survival during development, although NGF
contributes together with TGFβ to the Schwann cell death in
injured nerves (Syroid et al., 2000).
HDAC1/2 is also involved in Schwann cell survival pathways,
since substantial cell death is seen from postnatal day 2 onwards
in mice in which HDAC1/2 has to be inactivated at the SCP/iSch
stage (Jacob et al., 2011).
Laminin, a major component of the basal lamina, can
promote Schwann cell survival in vitro independently of the
potential function of laminin as a mitogen discussed below (see
‘‘Nerve Fasciculation and the Formation of the Neuromuscular
Junction’’ section; Meier et al., 1999). Other studies confirm
that plating Schwann cells on laminin results in increased cell
numbers, but have not determined whether this effect is due
to the promotion of survival or proliferation (McGarvey et al.,
1984; Yang et al., 2005; Yu et al., 2005, 2009). In vivo, Schwann
cell death is also increased after genetic inactivation of laminin
in Schwann cells (Yu et al., 2005; Chernousov et al., 2008;
Feltri et al., 2016).
A large number of soluble signals, including NRG1, promote
Schwann cell survival in vitro or when exogenously applied to
Schwann cells in vivo (reviewed in Jessen and Mirsky, 2013).
Mitogens
In vivo, BrdU incorporation indicating DNA synthesis is seen
in SCP, and at gradually increasing levels in iSch to reach a
peak just before birth (Stewart et al., 1993). After birth, DNA
synthesis declines rapidly as iSch are induced to assume first
Frontiers in Molecular Neuroscience | www.frontiersin.org 10 March 2019 | Volume 12 | Article 69
Jessen and Mirsky Schwann Cell Development
the myelin and then the Remak phenotypes (Stewart et al., 1993).
Evidence that axons drive Schwann cell proliferation comes
from the observation that nerve transection in neonatal rodents,
which leads to axonal degeneration, results in the decline
in proliferation (Komiyama and Suzuki, 1992), and from the
localization of potential mitogens such as Notch ligands and
NRG1 on axonal membranes. Similarly, in vitro contact between
axons and Schwann cells leads to Schwann cell proliferation
(Salzer and Bunge, 1980).
NRG1 is commonly implicated as a significant component
of the mitogenic signal between axons and Schwann cells.
In support, exposure to soluble NRG1 drives cell division
in cultured Schwann cells, and in co-cultures, the mitogenic
effect of axons on Schwann cells is mediated by NRG1
(Morrissey et al., 1995). Also, in zebrafish blockers of
ErbB2 NRG1 receptors reduce Schwann cell proliferation. In
rodents, however, direct evidence for the plausible notion that
NRG1 is an axon-associated mitogen is still missing.
There are also intriguing contrary findings. Thus, conditional
inactivation of ErbB2 NRG1 receptors in perinatal nerves results
in increased Schwann cell proliferation (Garratt et al., 2000b).
While this may be related to impairments in myelination seen
in these mice, the mitogen driving Schwann cell division in these
nerves is unlikely to be NRG1. In cyclin D1−/− mice, Schwann
cells also divide normally, although cell culture experiments
indicate that cyclin D1 is required for the mitogenic effect of
NRG1 (Garratt et al., 2000a,b; Kim et al., 2000; Atanasoski et al.,
2001; Finzsch et al., 2010). Lastly, in Sox10 mutants, mRNA
levels for the NRG1 receptor ErbB3 are substantially reduced in
Schwann cells although Schwann cell proliferation is unchanged
or increased (Finzsch et al., 2010). Injury of adult nerves results in
a transient wave of Schwann cell proliferation, which also appears
to be independent of ErBbB2 NRG1 receptors (Atanasoski et al.,
2001, 2006).
In addition to axons, signals that drive Schwann cell
proliferation during development also come from sources.
This includes laminin in the basal lamina since genetic
deletion of Schwann cell laminin (γ1 chain mutants or dy2J/α
double mutants) results in a drop in proliferation rate. Other
basal lamina-associated factors that promote Schwann cell
proliferation in vivo include the small Rho GTPase cdc42 and
focal adhesion kinase (FAK; Yu et al., 2005; Grove et al., 2007;
Chernousov et al., 2008; Feltri et al., 2008, 2016). Jun activation
domain-binding protein (Jab1) has been suggested to mediate
signaling downstream of laminin 211, and genetic inactivation
of Jab1 in Schwann cells results in reduced proliferation (Porello
et al., 2014). At least four other signaling pathways have been
shown to be involved in driving Schwann proliferation in
developing nerves in vivo, namely Notch, TGFβ, and the Hippo
and cAMP pathways.
Notch
Notch signaling is a major axonal driver of Schwann cell
proliferation in developing nerves. In vivo genetic inactivation
of Notch selectively in Schwann cells results in about 50%
reduction in Schwann cell DNA synthesis in developing nerves,
and this is accompanied by a reduction in Schwann cell numbers
(Woodhoo et al., 2009). Notch ligands are also expressed on
peripheral axons. Further, in vitro Notch activation in Schwann
cells is strongly mitogenic (Woodhoo et al., 2009).
TGFβ
Potentially, TGFβ has two distinct effects on Schwann cells,
induction of death as discussed above (see ‘‘Signals Regulating
Survival and Death’’ section), and induction of DNA synthesis.
Both effects can be seen in vitro depending on culture conditions
(Einheber et al., 1995; Parkinson et al., 2001). Both effects can
also be seen in vivo (D’Antonio et al., 2006a). When TGFβ
type II receptor is genetically inactivated selectively in Schwann
cells to abolish TGFβ signaling, Schwann cell DNA synthesis
in developing nerves is substantially reduced, showing that
TGFβ takes part in driving Schwann cell proliferation in vivo
(D’Antonio et al., 2006a). On the other hand, the rate of normal
developmental Schwann cell death is also reduced. The result is
that in developing nerves, abolishing TGFβ signaling does not
materially affect Schwann cell numbers.
When TGFβ alone is applied to Schwann cells in culture, it
induces apoptosis, but when this factor is applied in medium
containing NRG1, TGFβ induces DNA synthesis (Parkinson
et al., 2001; D’Antonio et al., 2006a). Therefore, it has been
suggested that in developing nerves, the role of TGFβ is to
amplify the proliferation of cells with tight axonal contact
(and therefore exposure to axonal NRG1), while promoting
the death of cells with a less effective axonal association
(D’Antonio et al., 2006a).
The Hippo Pathway
Yap and Taz, key components of the Hippo signaling pathway,
are expressed in Schwann cells. Genetic inactivation of either
of these factors does not substantially affect early Schwann
cell development. Combined inactivation of both Yap and Taz,
however, results in a large reduction in proliferation of iSch,
in addition to causing major changes in subsequent Schwann
cell development including radial sorting and myelination. Yap
and Taz exert their control over Schwann cell proliferation via
the transcription factor TEA domain family member 1 (TEAD1;
Poitelon et al., 2016; Deng et al., 2017; Grove et al., 2017).
The cAMP Pathway
In Schwann cells, genetic inactivation of the R1A regulatory
subunit of protein kinase A, a key down-stream mediator in the
cAMP signaling pathway, leads to severe drop in proliferation
(Guo et al., 2013). The G protein-coupled receptor (GPR)126 is
linked to cAMP elevation in Schwann cells and implicated in
the control of Schwann cell proliferation (Monk et al., 2009,
2015). Also in cell culture, agents that mimic or moderately
elevate cAMP levels drive Schwann cell division provided they
are applied in combination with serum or defined growth
factors such as NRG1 (Morgan et al., 1991; Monje et al., 2009;
Arthur-Farraj et al., 2011). If cAMP levels are increased in such
cultures, the mitogenic effect of cAMP gradually gives way to
cAMP-induced activation of myelin genes (Arthur-Farraj et al.,
2011). In a defined medium without growth factors, the effect of
cAMP is primarily that of up-regulating myelin genes without
significant stimulation of cell division (Morgan et al., 1991).
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SCHWANN CELLS IN POSTNATAL NERVES
The details of postnatal Schwann cell development and the
biology of Schwann cells in older nerves have been the subject
of numerous reviews, and lie outside the scope of this article
(e.g., Jessen and Mirsky, 2005a, 2008, 2016, 2019; Taveggia
et al., 2010; Glenn and Talbot, 2013; Jessen et al., 2015b;
Monk et al., 2015; Salzer, 2015; Feltri et al., 2016; Boerboom
et al., 2017; Ma and Svaren, 2018; Stassart et al., 2018;
Jessen and Arthur-Farraj, 2019).
Briefly, all iSch in perinatal nerves are thought to have the
same developmental potential. Some of them randomly come
to assume a 1:1 relationship with larger diameter axons due to
morphogenetic movements within the Schwann cell families (see
‘‘The Architectural Transformation of Nerve: the Generation of
Connective Tissue’’ section; Figure 4B), referred to as radial
sorting. Signals from the axons and the surrounding basal lamina
activate the myelin program in these cells and drive them to
assume the myelin phenotype, forming the electrically insulating
myelin sheaths, required for fast conduction of action potentials.
The smaller axons remaining in the families gradually assume
a position in shallow troughs in the surface of Schwann cells
thereby forming the unmyelinated Remak fibers.
The induction of Schwann cells to myelinate represents a
striking example of cell extrinsic signals, in this case from
axons and basal lamina, controlling phenotypic transformation
during development. The fact that the highly specialized myelin
Schwann cell phenotype generated through these interactions
is not stable, but can be readily dismantled is another feature
of particular interest in this system. This takes place in
demyelinating neuropathies, and after nerve injury when axons
degenerate, and myelin (and Remak) cells respond to the
loss of axonal contact and other injury-related disturbance by
transforming to an alternative Schwann cell phenotype that
promotes nerve regeneration, repair Schwann cells (see ‘‘The
Plasticity of the Schwann Cell Phenotype’’ section).
The remarkable plasticity of Schwann cells, their dependence
on environmental signals and ability to adapt to the needs of the
tissue they find themselves in, is underscored by the fact that
when regeneration is accomplished and repair cells are no longer
needed, they obey axon-associated signals to transform back to
assume the myelin and Remak phenotypes necessary for normal
nerve function.
CONCLUSIONS
Glial cells are a central cellular component both of the PNS,
where these cells develop form the neural crest, and the CNS,
where they develop from the neuroepithelium. Notably, the key
early stage in the development of both of these glial lineages, the
SCP in the PNS and the radial glia in the CNS, share the stem-
cell-like feature of developmental multipotency. At the same
time, these cells show an obvious glial phenotype in terms of
molecular, cell biological and structural features. Thus, SCP, like
the iSch they give rise to, are embedded among, and ensheath
axons, are strikingly dependent on axon-associated signals for
development, and express a number of molecular markers
associated with glial cells. At the same time, some of these cells
contribute to the generation on fibroblasts, melanocytes and
autonomic neurons during embryonic development, in addition
to their major fate, the conversion to iSch. This transition takes
place in late embryonic nerves, while postnatally iSch diverge to
generate the myelin and Remak Schwann cells essential for the
function of adult nerves.
These postnatal Schwann cells states retain a high degree of
plasticity. For instance, during the normal physiological response
to injury in vivo Schwann cells temporarily assume a repair
Schwann cell phenotype that is crucial for regeneration, and as
nerves regenerate former myelin cells can convert to Remak cells
and vice versa. However, there is no clear evidence yet that under
physiological circumstances Schwann cells can revert to the SCP
stage, or that SCP—like cells take part in the injury response of
peripheral nerves. Since SCP also have not been demonstrated
in adult nerves, this cell appears to be unique to developing
embryonic nerves.
In recent years, important transcription factors, epigenetic
mechanisms and cell-extrinsic signals that control major events
in the Schwann cell lineage have been identified. Nevertheless,
significant gaps remain, particularly regarding our knowledge
of the molecular controls of early events in embryonic nerves,
such as the generation of SCP, lineage choice by SCP, and
the architectural nerve transformation that takes place at the
SCP/iSch transition.
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